Interbio Biology & Technology

Company Deals

Beijing Interbio Secures Pre-Series A Funding for SPR Technology Expansion

Fineline Cube Jan 17, 2023

Beijing Interbio Biology & Technology Co., Ltd, a China-based company specializing in surface plasmon resonance...

Company Drug

InnoCare’s Zurletrectinib Wins NMPA Nod as China’s First Next-Gen TRK Inhibitor

Company Deals

Brii Biosciences Taps OpenBench AI Platform to Accelerate Drug Discovery

Company Deals

GSK Terminates Ideaya Synthetic Lethality Partnership, Returns Two Clinical Programs

Company Deals

B&K Corporation Debuts on HKEX in $900M IPO Backed by Burn Drug Pipeline